Switch theme
Sign up to access all valuation multiples
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
1987
7.4K+
LTM Revenue $1.4B
LTM EBITDA $321M
$6.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Merit Medical Systems has a last 12-month revenue (LTM) of $1.4B and a last 12-month EBITDA of $321M.
In the most recent fiscal year, Merit Medical Systems achieved revenue of $1.4B and an EBITDA of $296M.
Merit Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Merit Medical Systems valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| Gross Profit | $706M | XXX | $643M | XXX | XXX | XXX |
| Gross Margin | 50% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | $321M | XXX | $296M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $255M | XXX | $156M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $205M | XXX | $120M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $353M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Merit Medical Systems's stock price is $95.
Merit Medical Systems has current market cap of $5.6B, and EV of $6.0B.
See Merit Medical Systems trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.0B | $5.6B | XXX | XXX | XXX | XXX | $3.41 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Merit Medical Systems has market cap of $5.6B and EV of $6.0B.
Merit Medical Systems's trades at 4.5x EV/Revenue multiple, and 20.4x EV/EBITDA.
Equity research analysts estimate Merit Medical Systems's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Merit Medical Systems has a P/E ratio of 27.4x.
See valuation multiples for Merit Medical Systems and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.6B | XXX | $5.6B | XXX | XXX | XXX |
| EV (current) | $6.0B | XXX | $6.0B | XXX | XXX | XXX |
| EV/Revenue | 4.3x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBITDA | 18.8x | XXX | 20.4x | XXX | XXX | XXX |
| EV/EBIT | 23.7x | XXX | 38.7x | XXX | XXX | XXX |
| EV/Gross Profit | 8.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.4x | XXX | 46.7x | XXX | XXX | XXX |
| EV/FCF | 35.2x | XXX | 33.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMerit Medical Systems's last 12 month revenue growth is 8%
Merit Medical Systems's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Merit Medical Systems's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Merit Medical Systems's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Merit Medical Systems and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 26% | XXX | 30% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Merit Medical Systems acquired XXX companies to date.
Last acquisition by Merit Medical Systems was XXXXXXXX, XXXXX XXXXX XXXXXX . Merit Medical Systems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Merit Medical Systems founded? | Merit Medical Systems was founded in 1987. |
| Where is Merit Medical Systems headquartered? | Merit Medical Systems is headquartered in United States of America. |
| How many employees does Merit Medical Systems have? | As of today, Merit Medical Systems has 7.4K+ employees. |
| Who is the CEO of Merit Medical Systems? | Merit Medical Systems's CEO is Mr. Fred P. Lampropoulos. |
| Is Merit Medical Systems publicy listed? | Yes, Merit Medical Systems is a public company listed on NAS. |
| What is the stock symbol of Merit Medical Systems? | Merit Medical Systems trades under MMSI ticker. |
| When did Merit Medical Systems go public? | Merit Medical Systems went public in 1992. |
| Who are competitors of Merit Medical Systems? | Similar companies to Merit Medical Systems include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Merit Medical Systems? | Merit Medical Systems's current market cap is $5.6B |
| What is the current revenue of Merit Medical Systems? | Merit Medical Systems's last 12 months revenue is $1.4B. |
| What is the current revenue growth of Merit Medical Systems? | Merit Medical Systems revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Merit Medical Systems? | Current revenue multiple of Merit Medical Systems is 4.3x. |
| Is Merit Medical Systems profitable? | Yes, Merit Medical Systems is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Merit Medical Systems? | Merit Medical Systems's last 12 months EBITDA is $321M. |
| What is Merit Medical Systems's EBITDA margin? | Merit Medical Systems's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Merit Medical Systems? | Current EBITDA multiple of Merit Medical Systems is 18.8x. |
| What is the current FCF of Merit Medical Systems? | Merit Medical Systems's last 12 months FCF is $171M. |
| What is Merit Medical Systems's FCF margin? | Merit Medical Systems's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Merit Medical Systems? | Current FCF multiple of Merit Medical Systems is 35.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
